Comparison

Ozempic vs Wegovy

Same active ingredient, two different products. Here's what actually separates Ozempic and Wegovy in South Africa — and which makes sense for weight loss.

Medically reviewed by an HPCSA-registered doctor Last updated 5 sources

The quick answer

Both are semaglutide. The key differences: Wegovy is registered in SA for weight management and reaches a higher dose (2.4 mg), while Ozempic is registered for diabetes (weight-loss use is off-label) and tops out at 2 mg. For pure weight loss, Wegovy is the on-label choice; Ozempic is often used where Wegovy stock or price is a problem.

Ozempic vs Wegovy: side by side

Side-by-side · indicative SA data · June 2026
FeatureOzempicWegovy
Active ingredientSemaglutideSemaglutide (higher dose)
SA registrationType 2 diabetesChronic weight management
For weight lossOff-labelOn-label
Max dose2 mg weekly2.4 mg weekly
Avg. weight lossSlightly less (lower max dose)~15% (STEP, at 2.4 mg)
Typical price / monthR2 700 – R3 300R1 900 – R3 750 (after 2026 cuts)
Launched in SAEstablishedAugust 2025

Which might suit you

Lean Wegovy for weight loss specifically — it's registered for it, reaches the studied 2.4 mg dose, and became more competitively priced after the 2026 cuts. Lean Ozempic if it's what's available, if you have diabetes, or if a lower dose suits you. They're the same molecule, so the experience is broadly similar.

This is general information, not a recommendation for your situation. The right choice depends on your health, budget, what's in stock and a clinician's judgement. Get a personalised assessment from a registered provider

Read more

Frequently asked questions

Effectively yes — same ingredient (semaglutide), but Wegovy is titrated to a higher target dose and is registered for weight management rather than diabetes.

After the March 2026 price cuts, Wegovy can be cheaper at lower doses; at maintenance they're broadly comparable. Check the price guide.

Doctors do prescribe Ozempic off-label for weight loss, especially during Wegovy supply gaps. It's a clinical decision.

Sources & references

We cite primary sources and paraphrase them. Last reviewed June 2026. See our editorial policy and full sources hub.

  1. 1STEP programme — semaglutide for weight managementNew England Journal of Medicine (Wilding et al., STEP 1, 2021). Average weight loss with semaglutide 2.4 mg (~15% at 68 weeks).
  2. 2SAHPRA — registered health products & safety alertsSouth African Health Products Regulatory Authority. SA registration status of medicines and counterfeit / falsified-product warnings.
  3. 3SA Medicine Price Registry (SEP database)National Department of Health. Single Exit Price reference for medicines sold in SA.
  4. 4Which breakthrough weight-loss medicines can you get in SA?Spotlight. SA availability and registration context for GLP-1 medicines.
  5. 5Manufacturer Patient Information Leaflets (Novo Nordisk / Eli Lilly)Novo Nordisk; Eli Lilly. Approved dosing, administration and side-effect information.
Next step

Thinking about treatment?

These are prescription medicines, so they are not right for everyone and can't be bought over the counter. A registered provider can assess whether one is appropriate for you, start you safely and arrange a genuine product from a licensed pharmacy.

Book a consultation → Registered providers · genuine medicines · licensed pharmacies